ELVN Competitors & Alternatives
Compare Enliven Therapeutics Inc. with similar stocks in the same industry
Biotechnology
ELVN
Main Stock$47.54
-2.58%
Tradestie Score
34
Market Cap
$1.17B
Analyst Upside
+56.4%
Top Competitors
214 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$23.74
-3.50%
|
$3.83B | - | 44 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$13.43
-8.14%
|
$3.68B | - | 51 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$92.92
-1.14%
|
$3.67B | - | 38 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$13.70
+0.11%
|
$3.59B | 17.2 | 28 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$19.07
+1.71%
|
$3.58B | 8.6 | 47 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$304.93
-1.25%
|
$3.49B | 127.0 | 45 | Compare |
|
TLX
Telix Pharmaceuticals Limited American Depositary Shares
|
$8.99
-2.65%
|
$3.40B | 93.6 | 58 | Compare |
|
QURE
uniQure N.V.
|
$22.02
-7.52%
|
$3.39B | - | 51 | Compare |
|
SRRK
Scholar Rock Holding Corporation Common Stock
|
$43.21
+0.01%
|
$3.33B | - | 56 | Compare |
|
NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
$19.76
-1.89%
|
$3.31B | - | 49 | Compare |
More ELVN Analysis
Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2834)
214 stocks in this industry